ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 136 filers reported holding ANAPTYSBIO INC in Q3 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $764,831 | +19.0% | 30,520 | +7.0% | 0.00% | – |
| Q1 2024 | $642,496 | -1.9% | 28,530 | -6.7% | 0.00% | – |
| Q4 2023 | $655,238 | +19.3% | 30,590 | 0.0% | 0.00% | – |
| Q3 2023 | $549,396 | -16.9% | 30,590 | -5.9% | 0.00% | – |
| Q2 2023 | $661,457 | +6.3% | 32,520 | +13.7% | 0.00% | – |
| Q1 2023 | $622,336 | -38.4% | 28,600 | -12.3% | 0.00% | – |
| Q4 2022 | $1,010,274 | +21.4% | 32,600 | 0.0% | 0.00% | – |
| Q3 2022 | $832,000 | +25.7% | 32,600 | 0.0% | 0.00% | – |
| Q2 2022 | $662,000 | -6.1% | 32,600 | +14.4% | 0.00% | – |
| Q1 2022 | $705,000 | -28.6% | 28,500 | +0.4% | 0.00% | – |
| Q4 2021 | $987,000 | +19.8% | 28,400 | -6.6% | 0.00% | – |
| Q3 2021 | $824,000 | +4.6% | 30,400 | 0.0% | 0.00% | – |
| Q2 2021 | $788,000 | +32.9% | 30,400 | +10.5% | 0.00% | – |
| Q1 2021 | $593,000 | -11.4% | 27,500 | -11.6% | 0.00% | – |
| Q4 2020 | $669,000 | +40.8% | 31,100 | -3.4% | 0.00% | – |
| Q3 2020 | $475,000 | -33.9% | 32,200 | 0.0% | 0.00% | – |
| Q2 2020 | $719,000 | +39.3% | 32,200 | -11.7% | 0.00% | – |
| Q1 2020 | $516,000 | -71.2% | 36,486 | -66.9% | 0.00% | -100.0% |
| Q4 2019 | $1,790,000 | +40.2% | 110,130 | +201.8% | 0.00% | 0.0% |
| Q3 2019 | $1,277,000 | -36.6% | 36,486 | +2.2% | 0.00% | 0.0% |
| Q2 2019 | $2,013,000 | -4.0% | 35,686 | +24.4% | 0.00% | 0.0% |
| Q1 2019 | $2,096,000 | -51.7% | 28,686 | -57.9% | 0.00% | -66.7% |
| Q4 2018 | $4,343,000 | +54.4% | 68,086 | +141.6% | 0.00% | +50.0% |
| Q3 2018 | $2,812,000 | +40.5% | 28,186 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $2,002,000 | -20.5% | 28,186 | +16.5% | 0.00% | -50.0% |
| Q1 2018 | $2,517,000 | +19.1% | 24,186 | +15.2% | 0.00% | 0.0% |
| Q4 2017 | $2,114,000 | – | 20,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,316,447 | $147,766,000 | 38.13% |
| Cormorant Asset Management, LP | 1,105,557 | $70,523,000 | 5.73% |
| Ghost Tree Capital, LLC | 140,000 | $8,931,000 | 3.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 743,439 | $47,424,000 | 1.90% |
| BVF INC/IL | 220,265 | $14,051,000 | 1.84% |
| PFM Health Sciences, LP | 605,345 | $38,615,000 | 1.03% |
| Redmile Group, LLC | 364,050 | $23,223,000 | 0.93% |
| Partner Investment Management, L.P. | 6,731 | $429,000 | 0.54% |
| Endurant Capital Management LP | 12,734 | $812,000 | 0.43% |
| Rock Springs Capital Management LP | 136,000 | $8,675,000 | 0.41% |